We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Assay Quantifies CMV Deoxyribonucleic Acid from Human Plasma

By LabMedica International staff writers
Posted on 07 Jul 2014
A flexible, fully automated, random access molecular diagnostics system for the quantitative and qualitative analysis of molecular targets from clinical patient specimens has been developed.

The VERIS system developed by Beckman Coulter Diagnostics (Brea, CA, USA) integrates key steps in molecular diagnostics to streamline workflow and system management, while processing critical STAT samples and ensuring prompt delivery of results. By providing continuous access, one-step loading, and individual test reporting, VERIS helps medical laboratory professionals advance and optimize the molecular diagnostics lab, by providing the control and freedom to give the right answer at the right time—for patients and physicians.

The CMV assay is a polymerase chain reaction (PCR) assay designed for the quantitative determination of CMV deoxyribonucleic acid (DNA) from human plasma. When used in conjunction with clinical presentation and other laboratory findings, the CMV assay aids in monitoring CMV viral load.

Beckman Coulter Diagnostics obtained the CE marking for the VERIS MDx System and VERIS human Cytomegalovirus (CMV) assay: a key milestone in the expansion of Beckman Coulter’s presence in molecular diagnostics.

Beckman Coulter is committed to the ongoing development of assays to expand the VERIS infectious disease portfolio and plans to submit for CE marking on assays for Human Immunodeficiency Virus (HIV), Hepatitis C virus (HCV) and Hepatitis B virus (HBV) in 2014.

Richard Creager, senior vice president, molecular diagnostics business unit, and CSO at Beckman Coulter Diagnostics, commented, “After extensive research and development, Beckman Coulter has applied its expertise in diagnostics with our in‐depth knowledge of workflow to bring molecular diagnostics to the clinical laboratory. We have spent tremendous effort on understanding the needs of molecular laboratory professionals to develop a system that simplifies molecular diagnostic testing, while delivering the results that patients and clinicians need.”

Related Links:

Beckman Coulter Diagnostics



New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Latest Microbiology News

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment